Manufacturers of SARS-COV-2 injections are getting slated by FDA—why are they still producing?
...who knows what's going into your body?
It’s not a secret—Fierce Pharma is reporting it!
FiercePharma is reporting horrific FDA findings at facilities manufacturing the SARS-CoV-2 injections. In spite of this proven substandard manufacture, they are still pumping out products that are potentially adulterated—which means they should cease production immediately. Let’s take a look at some of what Fierce Pharma has published, including copies of the reports FDA issued:
Moderna's new booster launch tripped up by production issues at Catalent plant
“On Tuesday night, the FDA released (PDF) a Form 483 notice it had sent to Catalent, citing 12 observations from a lengthy August inspection of its Bloomington, Indiana, site. The massive facility is among the largest in the portfolio of contract manufacturing powerhouse Catalent. Most of the observations had to do with quality control, record keeping and the failure to establish and follow procedures. The FDA noted a failure to address unexplained discrepancies in a batch of drug prod…